Leerink Partners Reiterates Outperform Rating on Fulcrum Therapeutics (FULC)
Go back to Leerink Partners Reiterates Outperform Rating on Fulcrum Therapeutics (FULC)| (NASDAQ: FULC) | Delayed: 3.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.56 | 52 Week High | $ | |||
| Open | $3.56 | 52 Week Low | $ | |||
| Day High | $3.56 | P/E | N/A | |||
| Day Low | $3.56 | EPS | $ | |||
| Volume | 97,773 | |||||

